F.D.A. Approves the First New Schizophrenia Drug in Decades


By Ellen Barry and Christina Jewett from NYT Health https://ift.tt/MZaKlLi
Regulation and Deregulation of Industry, Schizophrenia, Therapy and Rehabilitation, Drugs (Pharmaceuticals), Psychology and Psychologists, Clinical Trials, Weight, Dopamine, Psychiatry and Psychiatrists, Research
Previous Post Next Post

Contact Form